Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 16/20 | 0.46 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.43 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.43 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.43 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.42 |
| ▸ | MERTK | Q12866 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12351087 | 1.00 | PIM1 (0.46) | PIM1PIM3PIM2MKNK1AAK1 | |
| SCHEMBL12350791 | 0.92 | PIM1 (0.49) | PIM1PIM3PIM2IKBKB | |
| SCHEMBL12350683 | 0.91 | MERTK (0.52) | PIM1PIM3PIM2MKNK1AAK1 | |
| SCHEMBL12351050 | 0.88 | PIM1 (0.46) | PIM1PIM3PIM2MKNK1IKBKB | |
| SCHEMBL2355850 | 0.88 | PIM1 (0.46) | PIM1PIM3PIM2MKNK1IKBKB | |
| SCHEMBL12350795 | 0.88 | PIM1 (0.47) | PIM1PIM3PIM2MKNK1IKBKB | |
| SCHEMBL2358068 | 0.88 | PIM1 (0.47) | PIM1PIM3PIM2MKNK1IKBKB | |
| SCHEMBL12350723 | 0.85 | PIM1 (0.51) | PIM1PIM3PIM2MKNK1KCNH2 | |
| SCHEMBL2356754 | 0.84 | PIM1 (0.49) | PIM1PIM3PIM2MKNK1KCNH2 | |
| SCHEMBL12351021 | 0.84 | PIM1 (0.49) | PIM1PIM3PIM2MKNK1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011101640-A1 | FUSED HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF MALARIA | MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) | 2011-08-25 | — | — | WO | disclosed |